Tenaya Therapeutics, Inc. (NASDAQ: TNYA)
$1.4350
+0.0150 ( +1.06% ) 974.5K
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
Market Data
Open
$1.4350
Previous close
$1.4200
Volume
974.5K
Market cap
$109.66M
Day range
$1.3260 - $1.4600
52 week range
$0.9867 - $7.0100
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Jul 25, 2024 |
| 8-k | 8K-related | 11 | Jun 27, 2024 |
| 8-k | 8K-related | 11 | May 31, 2024 |
| 10-q | Quarterly Reports | 58 | May 14, 2024 |
| 8-k | 8K-related | 13 | May 14, 2024 |
| ars | Annual reports | 1 | Apr 17, 2024 |
| def | Proxies and info statements | 5 | Apr 17, 2024 |
| 10-k | Annual reports | 69 | Mar 18, 2024 |
| 8-k | 8K-related | 13 | Mar 18, 2024 |
| 4 | Insider transactions | 1 | Mar 06, 2024 |